Form 4: Director William G. Kaelin Jr. Acquires IQVIA Deferred Shares

IQVIA Holdings Inc. director William G. Kaelin Jr. was granted 1,571 deferred shares as part of director compensation.

Summary

• Director William G. Kaelin Jr. acquired 1,571 deferred shares of IQVIA Holdings Inc. common stock.
• The transaction occurred on April 23, 2026, at a price of $160.68 per share.
• These deferred shares are part of the company's Non-Employee Director Deferral Plan.
• The shares are convertible into common stock upon the director's departure, a change in control, or death.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it reflects standard director compensation rather than a strategic shift or market-moving event.

Positives

• Demonstrates alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified; this is a standard director compensation disclosure.

Risks

• Value of deferred shares is subject to market fluctuations in IQVIA common stock price.

Future Outlook

The deferred shares will convert to common stock upon the director's cessation of service, a change in control, or death, with no expiration date.

Industry Context

StockSavvy.ai notes that this filing represents routine corporate governance activity regarding director compensation within the healthcare technology and clinical research services sector.

Comparison to Industry Standards

• The use of deferred share units for non-employee directors is a standard practice among S&P 500 companies to align board incentives with long-term performance.

Corporate Governance

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity-based compensation grant.

Next Steps

• The reporting person will hold these deferred shares until a qualifying event triggers conversion to common stock.

Key Dates

Keywords

IQVIA, IQV, Director Compensation, Insider Transaction, Form 4, Equity Grant